1Van Cutsem E,et al.The treatment of advanced gastric cancer:new findings on the activity of the taxanes[J].The Oncologist,2004,9(12):9.
2Shah MA,Schwartz GK,et al.Treatment of metastatic esophagus and gastric cancer[J].Semin Oncol,2004,31(4):575.
3Glimelius B,Ekstrom K,Hoffman K,et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer[J].Ann Oncol,1997,8(2):163.
4Ohtsu A,Shimada Y,Shirao K,et al.Randomized phase Ⅲ trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable,advanced gastric cancer the Japan Clinical Oncology Group Study (JCOG9205)[J].J Clin Oncol,2003,21(1):54.
5Baoli Qin,Risa Tanaka,Yoshihiro Shibata,et al.In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines[J].Anticancer Drugs,2006 Apr;17(4):445.
6Louvet C,Andre T,Tigaud JM,et al.Phase Ⅱ study of oxaliplatin,fluorouracil,and folinic acid in locally advanced or metastatic gastric cancer patients[J].J Clin Oncol,2002,20(23):4543.
7De Vita F,Orditura M,Matano E,et al.A phase Ⅱ study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients[J].Br J Cancer,2005,92(9):1644.
8Lordick F,Lorenzen S,Stollfuss J,et al.Phase Ⅱ study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer[J].Br J Cancer,2005,93(2):190.
10Bang YJ,Kang WK,Kang YK,et al.Docetaxel 75 mg/m2m2 is active and well tolerated in patients with metastatic or recurrent gastric cancer:a phase Ⅱ trial[J].Jpn J Clin Oncol,2002,32(7):248.
2Giacchetti S, Perpoint B, Zidani R, et al. Phase Ⅲ multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol,2000,18:136-147.
3Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg,2004,240:644-657.
4Chao Y, Yeh KH, Chang CJ, et al. Phase Ⅱ study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer,2004,91:453-458.
5Louvet C, Andre T, Tigaud JM, et al. Phase Ⅱ study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol,2002,20:4543-4548.
6Al-Batran SE, Atmaca A, Hegewisch-Becker S, et al. Phase Ⅱ trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol,2004,22:658-663.
7Kim DY, Kim JH, Lee SH, et al. Phase Ⅱ study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer. Ann Oncol,2003,14:383-387.
8Moran RG, Scanlon KL. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid. Cancer Res,1991,51: 4618-4623.
9Eriguchi M, Levi F, Hisa T,et al. Chronotherapy for cancer. Biomed Pharmacother,2003,57(Suppl 1):92-95.
5Ajani JA.Evolving chemotherapy for advanced gastric cancer[J].The On-cologist,2005,10:49-58.
6Ajani JA,van Cutsem E,Moiseyenko V,et al.Docetaxel(D),cis-platin,5-fluorouracil compare to cisplatin(C)and 5-fluorouracil (F) for chemotherapy na ve patients with metastasis(MGC):interim results of a randomized phase III trial(V325)[J].Proc Am Soc Clin Oncol,2003,22(9):999.
